Financial Comparison: Envoy Medical (COCH) vs. The Competition

Envoy Medical (NASDAQ:COCH) is one of 51 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its rivals? We will compare Envoy Medical to similar businesses based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, risk and earnings.

Insider and Institutional Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for Envoy Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	401	1405	2528	116	2.53

Envoy Medical currently has a consensus price target of $9.00, suggesting a potential upside of 561.76%. As a group, “Surgical appliances & supplies” companies have a potential upside of 34.43%. Given Envoy Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Envoy Medical is more favorable than its rivals.

Profitability

This table compares Envoy Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Volatility & Risk

Envoy Medical has a beta of 2.35, indicating that its share price is 135% more volatile than the S&P 500. Comparatively, Envoy Medical’s rivals have a beta of 1.28, indicating that their average share price is 28% more volatile than the S&P 500.

Valuation & Earnings

This table compares Envoy Medical and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$225,000.00	-$29.91 million	-0.96
Envoy Medical Competitors	$1.41 billion	$234.66 million	19.77

Envoy Medical’s rivals have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Envoy Medical rivals beat Envoy Medical on 7 of the 13 factors compared.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.